Functional Analysis of Variants in BRCA1 Using CRISPR Base Editors.

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Traditional methods for evaluating BRCA gene variants of uncertain significance (VUS) have limitations, including overexpression artifacts and inability to assess post-transcriptional regulation.
• These limitations leave the functional impact of numerous BRCA VUS undefined, hindering accurate clinical interpretation and genetic counseling.

Purpose of the Study:

• To develop and describe a novel method for functional assessment of BRCA1 variants of uncertain significance (VUS).
• To overcome the limitations of existing assays, particularly concerning overexpression and post-transcriptional regulation.
• To enable precise functional characterization of BRCA1 VUS in living cells.

Main Methods:

• Utilized CRISPR-mediated base editing technology to introduce specific nucleotide substitutions in living cells.
• Developed a precise method for assessing the functionality of introduced BRCA1 variants.
• Focused on variants of uncertain significance (VUS) where functional data is currently lacking.

Main Results:

• Successfully implemented a CRISPR-based base editing system for functional appraisal of BRCA1 variants.
• Enabled precise introduction of target nucleotide substitutions, allowing for direct assessment of variant function.
• Identified functional consequences for previously uncharacterized BRCA1 variants.

Conclusions:

• CRISPR-based base editing offers a powerful and precise tool for evaluating the functional significance of BRCA1 variants of uncertain significance (VUS).
• This method overcomes key limitations of prior functional assays, providing a more accurate assessment of variant impact.
• The described approach facilitates a better understanding of BRCA1 VUS, potentially improving genetic risk assessment and therapeutic strategies.